ArticleFrontiers in neurology2025
Predictors of functional deterioration from 90 days to 1 year after endovascular treatment for vertebrobasilar artery occlusion: a multicenter retrospective study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Functional trajectories beyond 90 days after endovascular thrombectomy: a systematic review with primary synthesis and supportive narrative evidence.Frontiers in neurology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate risk factors for delayed neurological deterioration (1-year mRS score > 90-day score) in patients with acute ischemic stroke due to vertebrobasilar artery occlusion (VBAO) after endovascular treatment (EVT), and to evaluate heterogeneity across age and sex subgroups. Methods: This multicenter retrospective study included 1,342 VBAO patients who underwent EVT between December 2015 and June 2022. Based on dynamic changes in the mRS score, patients were categorized into a 1-year functional deterioration group ( Results: After adjusting for demographics and clinical variables, the following factors were independently associated with 1-year functional deterioration (all Conclusion: This study revealed that the functional outcomes of patients with VBAO from 90 days to 1 year after EVT exhibit distinct patterns, with the dominant influencing factors varying by gender and age group. This provides an important basis for the formulation of individualized treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.